Adult Pilocytic Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain 123I-FP-CIT SPECT of a Holmes Tremor Due to Midbrain Pilocytic Astrocytoma.
|
31306206 |
2020 |
Pilocytic Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain 123I-FP-CIT SPECT of a Holmes Tremor Due to Midbrain Pilocytic Astrocytoma.
|
31306206 |
2020 |
Tremor, Rubral
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain 123I-FP-CIT SPECT of a Holmes Tremor Due to Midbrain Pilocytic Astrocytoma.
|
31306206 |
2020 |
Childhood Pilocytic Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Brain 123I-FP-CIT SPECT of a Holmes Tremor Due to Midbrain Pilocytic Astrocytoma.
|
31306206 |
2020 |
Malignant neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Knockdown of CIT-K expression also inhibited breast cancer cell migration and invasion capacity.
|
30565087 |
2019 |
Impulsive Behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We performed <sup>123</sup> I-FP-CIT Single-photon emission computed tomography (SPECT) and correlated DAT binding ratios in the bilateral caudate and putamen with gambling symptoms (G-SAS, PG-YBOCS) and behaviors, as well as other psychometric variables (anhedonia and impulsivity).
|
30226290 |
2019 |
Multiple Myeloma
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study provides the rationale for CIT being a potential therapeutic target in MM in future trials.
|
30940634 |
2019 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The expression of a two-gene set, CIT and HSPB8 with an overall balanced accuracy of 98.8% and a threshold value of 0.2347, was sufficient to classify metastasis.
|
31273254 |
2019 |
Gambling, Pathological
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A <sup>123</sup> I-FP-CIT SPECT study.
|
30226290 |
2019 |
Anhedonia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We performed <sup>123</sup> I-FP-CIT Single-photon emission computed tomography (SPECT) and correlated DAT binding ratios in the bilateral caudate and putamen with gambling symptoms (G-SAS, PG-YBOCS) and behaviors, as well as other psychometric variables (anhedonia and impulsivity).
|
30226290 |
2019 |
Hypocupremia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Green synthesis of 1,4-disubstituted-1,2,3-triazoles via click reaction using nano magnetic Fe<sub>3</sub>O<sub>4</sub> core decorated with cyclodextrin-citric acid (Fe<sub>3</sub>O<sub>4</sub>@CD-CIT) acting as a phase transfer nanoreactor with low copper loading under ultrasonication at 40 °C, in aqueous media is described.
|
31299591 |
2019 |
Impaired cognition
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Cognition was measured using the Six-Item Cognitive Impairment Test (6-CIT).
|
31220173 |
2019 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
|
30565087 |
2019 |
Epithelial ovarian cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Univariate and multivariate analyses indicated that adjuvant CIT was an independent prognostic factor for the OS of patients with EOC.
|
30713783 |
2019 |
Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Knockdown of CIT-K expression also inhibited breast cancer cell migration and invasion capacity.
|
30565087 |
2019 |
Pancreatic carcinoma non-resectable
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, the CIT group exhibited a significantly higher overall survival rate for patients with unresectable metastatic pancreatic cancer compared with the TACE and control groups (P=0.0088 and P<0.0001, respectively), which suggests that a combination of different interventional techniques increases the survival of patients with unresectable pancreatic cancer.
|
31289509 |
2019 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Knockdown of CIT-K expression also inhibited breast cancer cell migration and invasion capacity.
|
30565087 |
2019 |
Deuteranomaly
|
0.010 |
Biomarker
|
disease |
BEFREE |
This image highlights that the early phases of F-FP-CIT PET may reflect regional cerebral perfusion with a pattern very similar to that of regional glucose metabolism in CBD.
|
30371594 |
2019 |
Anxiety
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the subgroup of patients not on DRT (n=81), we found a significant negative association between anxiety and thalamic <sup>123</sup>I-FP-CIT binding ratios bilaterally (right: β=-0.349, p=0.001, ΔR<sup>2</sup>=0.119; left: β=-0.269, p=0.017, ΔR<sup>2</sup>=0.071) (p<sub>corr</sub> <0.020).
|
28899958 |
2018 |
Anxiety Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
In the subgroup of patients not on DRT (n=81), we found a significant negative association between anxiety and thalamic <sup>123</sup>I-FP-CIT binding ratios bilaterally (right: β=-0.349, p=0.001, ΔR<sup>2</sup>=0.119; left: β=-0.269, p=0.017, ΔR<sup>2</sup>=0.071) (p<sub>corr</sub> <0.020).
|
28899958 |
2018 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
This retrospective study aimed to determine the clinical outcomes following particle monotherapy (ie, proton therapy [PT] or carbon ion therapy [CIT]) in patients with sinonasal squamous cell carcinoma at a single institution.
|
29859787 |
2018 |
Dyskinetic syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The association of quantitatively analyzed <sup>123</sup>I-FP-CIT binding in striatal subregions with the development of motor fluctuations, dyskinesias, freezing of gait (FOG) and falls as well as the time to Hoehn and Yahr (H&Y) stage 3 was evaluated.
|
29801899 |
2018 |
Ehlers-Danlos Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
We assessed and compared semi-quantified [<sup>123</sup>I]FP-CIT SPECT, and motor and non-motor features among these two groups, alongside exploring the clinical and imaging correlates of EDS and the predictive significance of these markers in the development of EDS.
|
29571867 |
2018 |
Osteoporosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Because CIT was more firmly combined with RANKL than IT, CIT had stronger anti-osteoporosis effect by inhibiting bone resorption.
|
30036771 |
2018 |
Prader-Willi Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mean brain-stem 5-HTT availability determined by [123I]-beta-CIT single photon emission tomography was lower in eight adults with mUPD PWS compared with nine adults with del PWS (mean difference -0.93, t = -2.85, P = 0.014).
|
29433608 |
2018 |